COMMISSION IMPLEMENTING REGULATION (EU) 2023/999
of 23 May 2023
renewing the approval of the active substance
Bacillus thuringiensis
subsp.
israelensis
strain AM65-52 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
(Text with EEA relevance)
Article 1
Renewal of the approval of the active substance
Article 2
Amendments to Implementing Regulation (EU) No 540/2011
Article 3
Entry into force and application
ANNEX I
Common Name, Identification Numbers |
IUPAC Name |
Purity(1) |
Date of approval |
Expiration of approval |
Specific provisions |
||||||||||
Bacillus thuringiensis subsp. israelensis strain AM65-52 Culture collection No ATCC 1276 |
Not applicable |
No relevant impurities |
1 July 2023 |
30 June 2038 |
The implementation of the uniform principles, provided for in Article 29(6) of Regulation (EC) No 1107/2009, requires that the conclusions of the renewal report on Bacillus thuringiensis subsp. israelensis strain AM65-52, and in particular Appendices I and II thereof, are taken into account. In this overall assessment, the Member States shall pay particular attention to:
Conditions of use shall include risk mitigation measures, such as:
|
ANNEX II
No. |
Common Name, Identification Numbers |
IUPAC Name |
Purity(1) |
Date of approval |
Expiration of approval |
Specific provisions |
||||||||||
‘161 |
Bacillus thuringiensis subsp. israelensis strain AM65-52 Culture collection No ATCC 1276 |
Not applicable |
No relevant impurities |
1 July 2023 |
30 June 2038 |
The implementation of the uniform principles, provided for in Article 29(6) of Regulation (EC) No 1107/2009, requires that the conclusions of the renewal report on Bacillus thuringiensis subsp. israelensis strain AM65-52, and in particular Appendices I and II thereof, are taken into account. In this overall assessment, the Member States shall pay particular attention to:
Conditions of use shall include risk mitigation measures, such as:
|